SCA
FBT icon

Snowden Capital Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Snowden Capital Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Buy
7,129
+468
+7% +$96.8K 0.04% 418
2025
Q4 		$1.38M Sell
6,661
-479
-7% -$95.7K 0.04% 424
2025
Q3 		$1.28M Buy
7,140
+897
+14% +$153K 0.04% 448
2025
Q2 		$1.01M Sell
6,243
-497
-7% -$79.2K 0.03% 514
2025
Q1 		$1.15M Buy
6,740
+38
+0.6% +$6.6K 0.04% 460
2024
Q4 		$1.11M Buy
6,702
+5,059
+308% +$864K 0.03% 480
2024
Q3 		$282K Sell
1,643
-680
-29% -$113K 0.01% 1023
2024
Q2 		$358K Sell
2,323
-488
-17% -$73.2K 0.01% 897
2024
Q1 		$432K Buy
2,811
+862
+44% +$131K 0.01% 825
2023
Q4 		$308K Hold
1,949
– – 0.01% 896
2023
Q3 		$285K Sell
1,949
-335
-15% -$51K 0.01% 882
2023
Q2 		$350K Buy
2,284
+6
+0.3% +$936 0.01% 891
2023
Q1 		$353K Sell
2,278
-121
-5% -$19K 0.01% 885
2022
Q4 		$370K Sell
2,399
-95
-4% -$14K 0.02% 847
2022
Q3 		$329K Sell
2,494
-70
-3% -$9.82K 0.01% 862
2022
Q2 		$347K Buy
2,564
+149
+6% +$20.5K 0.02% 802
2022
Q1 		$360K Buy
2,415
+140
+6% +$20.7K 0.01% 746
2021
Q4 		$368K Sell
2,275
-1,813
-44% -$293K 0.02% 519
2021
Q3 		$679K Buy
4,088
+66
+2% +$11.3K 0.03% 455
2021
Q2 		$694K Sell
4,022
-538
-12% -$88.9K 0.03% 456
2021
Q1 		$732K Sell
4,560
-1,187
-21% -$203K 0.04% 403
2020
Q4 		$965K Sell
5,747
-424
-7% -$68.8K 0.06% 310
2020
Q3 		$970K Buy
6,171
+5
+0.1% +$817 0.08% 274
2020
Q2 		$1.03M Sell
6,166
-294
-5% -$46.1K 0.09% 258
2020
Q1 		$847K Buy
6,460
+244
+4% +$34.8K 0.09% 264
2019
Q4 		$924K Buy
6,216
+2,234
+56% +$307K 0.08% 282
2019
Q3 		$493K Buy
3,982
+79
+2% +$10.5K 0.05% 343
2019
Q2 		$550K Buy
3,903
+680
+21% +$93.8K 0.06% 322
2019
Q1 		$486K Buy
3,223
+319
+11% +$45.9K 0.05% 326
2018
Q4 		$361K Buy
2,904
+905
+45% +$124K 0.05% 348
2018
Q3 		$317K Buy
1,999
+35
+2% +$5.3K 0.04% 386
2018
Q2 		$275K Buy
1,964
+320
+19% +$43.9K 0.04% 380
2018
Q1 		$218K Buy
+1,644
New +$224K 0.03% 355

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Snowden Capital Advisors's FBT Position: Q1 2026 in Review

Snowden Capital Advisors increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 7% in Q1 2026, buying an estimated $96.8K and bringing the position to 7,129 shares worth $1.43M. The position accounts for 0.04% of the portfolio, ranked #418.

Snowden Capital Advisors first reported a position in FBT in Q1 2018 and has held it in 33 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Snowden Capital Advisors held 7,129 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.43M as of Q1 2026.
  • Snowden Capital Advisors bought 468 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $96.8K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of Snowden Capital Advisors's portfolio in Q1 2026, its #418 holding.
  • Snowden Capital Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2018 and has held it in 33 quarters since.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.